AbbVie Discussion Space: How Do We Achieve HCV Elimination? Exploring Barriers and Strategies to Test-and-Treat
Tracks
Track 3
Track 4
Track 5
| Thursday, October 16, 2025 |
| 10:45 AM - 11:15 AM |
| Discussion Space |
Speaker
Doctor Brian Conway
President And Medical Director
Vancouver Infectious Diseases Centre
Welcome and Introductions
10:45 AM - 10:50 AMBiography
Tarik Asselah
Welcome and Introductions
10:45 AM - 10:50 AMBiography
Dr Stefan Bourgeois
Hepatologist
Ziekenhuis Aan de Stroom
Welcome and Introductions
10:45 AM - 10:50 AMBiography
Prof. Dr. Philip Bruggmann
Co-Head of Internal Medicine
Arud Centre for Addiction Medicine
Welcome and Introductions
10:45 AM - 10:50 AMBiography
AbbVie Symposium
Part 1: Test - Lifting Barriers and Expanding Access to HCV Care
10:50 AM - 11:00 AMNotes
Discuss strategies to improve access to testing for all people infected with HCV, focusing on high-risk groups (people who inject drugs and MSM). Discussion to cover barriers and solutions to testing from a system/provider level as well as from a patient level
Biography
AbbVie Symposium
Part 2: Treat - Addressing Acute HCV and HCV Reinfection
11:00 AM - 11:10 AMNotes
Discuss immediate treatment initiation and specifically address managing acute HCV cases, as well as reinfections within existing healthcare systems. Discussion to cover barriers and approaches to treatment without delay from a system, provider, and patient level
Biography
AbbVie Symposium
Close
11:10 AM - 11:15 AMBiography
